Contact Us
  Search
The Business Research Company Logo
Global Electrocardiogram (ECG) Telemetry Devices Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Electrocardiogram (ECG) Telemetry Devices Market Report 2026

Global Outlook – By Product (Event Monitoring And Mobile Cardiac Telemetry, Implantable Loop Recorders, Other Products), By Application (Arrhythmias, Myocardial Ischemia and Infarction, Pacemaker Monitoring, Other Applications), By End-User (Hospitals, Home Healthcare) – Market Size, Trends, Strategies, and Forecast to 2035

Electrocardiogram (ECG) Telemetry Devices Market Overview

• Electrocardiogram (ECG) Telemetry Devices market size has reached to $4.5 billion in 2025 • Expected to grow to $6.72 billion in 2030 at a compound annual growth rate (CAGR) of 8.3% • Growth Driver: Rising Cardiovascular Disease Burden Drives Increased Demand for ECG Telemetry Solutions • Market Trend: Advancing Cardiac Care Through Ai-Powered ECG Telemetry Innovation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Electrocardiogram (ECG) Telemetry Devices Market?

Electrocardiogram (ECG) telemetry devices are medical tools used to remotely monitor and record the electrical activity of a patient's heart over time. These devices are crucial in diagnosing and managing various heart conditions, such as arrhythmias, heart attacks, and other cardiovascular disorders. Electrocardiogram (ECG) telemetry devices are vital in inpatient and outpatient care, providing critical information that can lead to early detection and intervention for heart-related issues. The main product types of electrocardiogram (ECG) telemetry devices are event monitoring and mobile cardiac telemetry, implantable loop recorders, and others. Event monitoring and mobile cardiac telemetry devices are designed to record the heart's electrical activity over a specific period, especially during episodes of symptoms like palpitations or dizziness. These are used in various applications such as arrhythmias, myocardial ischemia and infarction, and pacemaker monitoring, and also by various end-users such as hospitals, and home healthcare.
Electrocardiogram (ECG) Telemetry Devices market report bar graph

What Is The Electrocardiogram (ECG) Telemetry Devices Market Size and Share 2026?

The electrocardiogram (ecg) telemetry devices market size has grown strongly in recent years. It will grow from $4.5 billion in 2025 to $4.88 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to limited access to remote monitoring technologies, reliance on hospital-based ECG monitoring, growing prevalence of cardiovascular diseases, expansion of outpatient care, increasing awareness of arrhythmia management.

What Is The Electrocardiogram (ECG) Telemetry Devices Market Growth Forecast?

The electrocardiogram (ecg) telemetry devices market size is expected to see strong growth in the next few years. It will grow to $6.72 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to advancement in wireless mobile cardiac telemetry, adoption of miniaturized implantable loop recorders, increasing integration of AI and predictive analytics, growth of home healthcare services, expansion of cloud-enabled ECG monitoring platforms. Major trends in the forecast period include rising adoption of remote cardiac monitoring solutions, integration of cloud-based ecg data management, growing demand for home healthcare cardiac telemetry, increased use of wearable and patch-based ecg devices, focus on early detection and management of cardiovascular disorders.
Research Expert

Book your 30 minutes free consultation with our research experts

Global Electrocardiogram (ECG) Telemetry Devices Market Segmentation

1) By Product: Event Monitoring And Mobile Cardiac Telemetry, Implantable Loop Recorders, Other Products 2) By Application: Arrhythmias, Myocardial Ischemia and Infarction, Pacemaker Monitoring, Other Applications 3) By End-User: Hospitals, Home Healthcare Subsegments: 1) By Event Monitoring And Mobile Cardiac Telemetry: Handheld Event Monitors, Wireless Mobile Cardiac Telemetry Devices, Real-Time Event Monitors, Patch-Based Event Monitors, Mobile ECG Telemetry Systems With Cloud Integration 2) By Implantable Loop Recorders: Subcutaneous Implantable Loop Recorders (ILRs), Wireless Implantable Loop Recorders, Long-Term Monitoring Implantable Loop Recorders, Miniaturized Implantable Loop Recorders, Remote Monitoring Implantable Loop Recorders 3) By Other Products: Holter Monitors, Wireless ECG Monitors, Smart Wearable ECG Devices, Patch-Based ECG Monitors, Portable ECG Telemetry Devices

What Is The Driver Of The Electrocardiogram (ECG) Telemetry Devices Market?

The rising burden of cardiovascular diseases is expected to propel the growth of the electrocardiogram (ECG) telemetry devices market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The rising burden of cardiovascular diseases (CVDs) can be attributed to unhealthy dietary habits, physical inactivity, tobacco use, excessive alcohol consumption, air pollution, and socioeconomic determinants such as poverty and stress. ECG telemetry devices enhance cardiovascular care by enabling continuous, real-time monitoring, supporting remote and home-based care, improving the functionality of implantable devices, aiding in accurate diagnosis and personalized treatment, and facilitating rapid emergency responses. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, an increase of 4.0% from 224.4 per 100,000 compared to 2023. Therefore, the rising burden of cardiovascular diseases is driving the electrocardiogram (ECG) telemetry devices industry.

Key Players In The Global Electrocardiogram (ECG) Telemetry Devices Market

Major companies operating in the electrocardiogram (ecg) telemetry devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., General Electric Company, Boston Scientific Corporation, Merit Medical Systems Inc., MicroPort Scientific Corporation, AtriCure Inc., Stereotaxis Inc., Kardium Inc., Hansen Medical Inc., Acutus Medical Inc., Imricor Medical Systems Inc., Osypka Medical GmbH, Biotronik SE & Co KG, Japan Lifeline Co Ltd, CardioFocus Inc, CathRx Ltd, Baylis Medical Company Inc, Ablacon Inc, Adagio Medical Inc, VytronUS Inc.

What Are Latest Mergers And Acquisitions In The Electrocardiogram (ECG) Telemetry Devices Market?

In May 2024, WearLinq Inc., a US-based provider of wearable health monitoring solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. With this acquisition, WearLinq, Inc. aims to expand access to its FDA 510(k)-cleared eWave 6-lead ECG monitor and enhance its ambulatory cardiac monitoring capabilities nationwide. AMI Cardiac Monitoring LLC is a US-based company that specializes in providing cardiac monitoring devices and services.

Need data on a specific region in this market?

Regional Outlook

North America was the largest region in the electrocardiogram (ECG) telemetry devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Electrocardiogram (ECG) Telemetry Devices Market?

The electrocardiogram (ECG) telemetry devices market consists of sales of ECG devices, stress ECG devices, holter monitors, event monitoring systems, and ECG management systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Electrocardiogram (ECG) Telemetry Devices Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$4.88 billion
Revenue Forecast In 2035$6.72 billion
Growth RateCAGR of 8.6% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredProduct, Application, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledJohnson & Johnson, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., General Electric Company, Boston Scientific Corporation, Merit Medical Systems Inc., MicroPort Scientific Corporation, AtriCure Inc., Stereotaxis Inc., Kardium Inc., Hansen Medical Inc., Acutus Medical Inc., Imricor Medical Systems Inc., Osypka Medical GmbH, Biotronik SE & Co KG, Japan Lifeline Co Ltd, CardioFocus Inc, CathRx Ltd, Baylis Medical Company Inc, Ablacon Inc, Adagio Medical Inc, VytronUS Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us